Reversible cardiomyopathy following treatment with amphotericin B and flucytosine

Int J Antimicrob Agents. 2008 Jun;31(6):582-4. doi: 10.1016/j.ijantimicag.2008.01.031. Epub 2008 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amphotericin B / adverse effects*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Blood Pressure / drug effects
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / diagnostic imaging
  • Cardiomyopathies / physiopathology
  • Cryptococcosis / complications
  • Cryptococcosis / drug therapy
  • Drug Carriers
  • Electrocardiography
  • Female
  • Flucytosine / adverse effects*
  • Flucytosine / therapeutic use
  • Heart / diagnostic imaging
  • Heart Function Tests
  • Heart Rate / drug effects
  • Humans
  • Liposomes
  • Middle Aged
  • Radionuclide Imaging

Substances

  • Antifungal Agents
  • Drug Carriers
  • Liposomes
  • Amphotericin B
  • Flucytosine